chevron_left
Oncology Drugs to Watch: ASCO 2025 Highlights
Clarivate’s oncology analysts bring you concise, strategic takeaways from this year’s ASCO event – covering key clinical developments, trial readouts, and implications for the future of cancer treatment.
What’s inside the report:
- Insights on 13 global oncology drugs tracked by Clarivate
- Late-phase clinical data highlights and trial outcomes
- Commercial and strategic implications from this year’s ASCO Annual Meeting
- Analyst perspectives on what’s next for each therapy
Download the report to get the latest insights.